Serum Trefoil Factor 3 in Endometrioid Endometrial Carcinoma: Exploratory Diagnostic Value and Association with Lymphovascular Space Invasion

Objectives: The primary objective of this exploratory study was to compare serum Trefoil factor family 3 (TFF3) levels among patients with grade 1–2 endometrioid endometrial cancer (EC), leiomyoma distorting the endometrial cavity, and healthy controls, and to explore the cross-sectional association between serum TFF3 and lymphovascular space invasion (LVSI) in EC. Methods: The prospective observational case–control study comprised three groups. The first group consisted of all grade I–II endometrioid-type EC patients who underwent hysterectomy at our institution. The second group comprised patients with leiomyoma causing compression in the endometrial cavity who also underwent hysterectomy. Patients with histopathological evidence of myoma after hysterectomy were included in the study. All patients who visited between January 2023 and January 2024 were enrolled in the first two groups. The third control group involved patients with normal findings on sonographic assessment who attended annual gynecological follow-up visits. Results: One hundred thirteen patients were enrolled in the study. Mean preoperative TFF3 levels were significantly higher in both EC and leiomyoma groups compared with controls, whereas EC and leiomyoma did not differ. Serum TFF3 decreased significantly on the first postoperative day in the EC group, whereas no significant change was observed in the leiomyoma group. Within the EC group, an exploratory comparison showed a significantly higher average TFF3 value in cases with lymphovascular space invasion (LVSI). Conclusions: Serum TFF3 is elevated in both benign and malignant pathologies involving the endometrial cavity and shows limited specificity for distinguishing EC from leiomyoma. The observed association with LVSI is preliminary and hypothesis-generating; larger, adequately powered studies are required before any diagnostic or prognostic role can be established.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-08-26
DOI
https://doi.org/10.3390/jcm15176598
Primary Topic
Galectins and Cancer Biology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum Trefoil Factor 3 in Endometrioid Endometrial Carcinoma: Exploratory Diagnostic Value and Association with Lymphovascular Space Invasion

Ertugrul Sen, Kemal Güngördük, Varol Gülseren, İbrahim Serdar Serin et al.
Journal of Clinical Medicine
Galectins and Cancer Biology
article

Serum Trefoil Factor 3 in Endometrioid Endometrial Carcinoma: Exploratory Diagnostic Value and Association with Lymphovascular Space Invasion

Ertugrul Sen, Kemal Güngördük, Varol Gülseren, İbrahim Serdar Serin, Merve Özel, Fulya Çağlı, Gülden Başkol, Bülent Özçelik, Bilgesu Çetinel Kaygun, Terlan Selin Kotan
article en

Abstract

Objectives: The primary objective of this exploratory study was to compare serum Trefoil factor family 3 (TFF3) levels among patients with grade 1–2 endometrioid endometrial cancer (EC), leiomyoma distorting the endometrial cavity, and healthy controls, and to explore the cross-sectional association between serum TFF3 and lymphovascular space invasion (LVSI) in EC. Methods: The prospective observational case–control study comprised three groups. The first group consisted of all grade I–II endometrioid-type EC patients who underwent hysterectomy at our institution. The second group comprised patients with leiomyoma causing compression in the endometrial cavity who also underwent hysterectomy. Patients with histopathological evidence of myoma after hysterectomy were included in the study. All patients who visited between January 2023 and January 2024 were enrolled in the first two groups. The third control group involved patients with normal findings on sonographic assessment who attended annual gynecological follow-up visits. Results: One hundred thirteen patients were enrolled in the study. Mean preoperative TFF3 levels were significantly higher in both EC and leiomyoma groups compared with controls, whereas EC and leiomyoma did not differ. Serum TFF3 decreased significantly on the first postoperative day in the EC group, whereas no significant change was observed in the leiomyoma group. Within the EC group, an exploratory comparison showed a significantly higher average TFF3 value in cases with lymphovascular space invasion (LVSI). Conclusions: Serum TFF3 is elevated in both benign and malignant pathologies involving the endometrial cavity and shows limited specificity for distinguishing EC from leiomyoma. The observed association with LVSI is preliminary and hypothesis-generating; larger, adequately powered studies are required before any diagnostic or prognostic role can be established.

Journal of Clinical MedicineVol. 15(17)
Izmir Kâtip Çelebi University (TR), Muğla University (TR), Erciyes University (TR)
Erciyes Üniversitesi
Good health and well-being
Openalex Percentile: Top 16%
Galectins and Cancer Biology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.